Biodiversity is foundational to human health, economic stability, and industrial resilience, particularly within the pharmaceutical sector, which is intrinsically dependent on natural ecosystems.
ESG
EU extends proposals to apply carbon border pricing to downstream products
EU member states have agreed to extend measures to price the carbon emissions of goods imported into the Eurozone to include a wide range of end-products made from steel, aluminum and iron. The current CBAM came into force on Jan. 1 this year and currently applies mainly to high-emission raw materials.
EU Council targets greenwashing with new categories of sustainable investment
The Council of the EU has recommended updates to the Sustainable Finance Disclosure Regulation to combat greenwashing and make it easier for investors to compare products.
ITM survey: Some organizations pull DEI programs—and some keep them—under feds’ DEI reversal, compliance officers report
Nearly four in 10 compliance teams have made it a priority to review risks related to their traditional DEI efforts and other programs in the face of the Trump administration’s unprecedented broadsides against the programs.
EU revised sustainability reporting standards require compliance ‘gear change’ but increase flexibility
The European Commission is calling for public feedback on the final draft of its revised sustainability reporting standards. Compliance teams should note that the draft retains most of the double materiality requirements that some hoped they would drop, but clarifications over how to approach materiality assessments may reduce compliance time and costs. Once the consultation […]
PayPal latest to settle with DOJ over a traditional DEI program
PayPal has agreed to end a loan program for black and minority-owned businesses as part of a settlement agreement with the U.S. Department of Justice, which accused the program of discriminating against white people.


